FDA device listing
Uric Acid2 (ARCHITECT; LN 04T1320, 04T1330)
FDA device listing 1361535590 · ABBOTT LABORATORIES
Key facts
| Proprietary names | Uric Acid2 (ARCHITECT; LN 04T1320, 04T1330) |
|---|---|
| Owner/operator | ABBOTT LABORATORIES |
| Owner/operator number | 1415939 |
| Product codes | CDO |
| Device names | CDO - Acid, Uric, Uricase (U.V.) |
| Device class | Class I |
| Classification regulations (21 CFR) | 862.1775 |
| Review panels | Clinical Chemistry |
| Registered establishments | ABBOTT GmbH, ABBOTT IRELAND DIAGNOSTICS DIVISION, ABBOTT LABORATORIES |
| Establishment registrations | 3002809144, 3005094123, 3005333358 |
| FEI numbers | 3002809144, 3005094123, 3005333358 |
| Establishment operations | Complaint File Establishment, Foreign Exporter, Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database